These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7129675)

  • 21. Increased mitochondrial uptake of rhodamine 123 during lymphocyte stimulation.
    Darzynkiewicz Z; Staiano-Coico L; Melamed MR
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2383-7. PubMed ID: 6941298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhodamine 123 alters the mitochondrial ultrastructure of cultured L1210 cells.
    Evenson DP; Lee J; Darzynkiewicz Z; Melamed MR
    J Histochem Cytochem; 1985 Apr; 33(4):353-9. PubMed ID: 3980984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mode of action of 5-fluorouridine 5'-phosphate in vivo and in vitro.
    Yoshida M; Kuretani K; Hoshi A
    Chem Pharm Bull (Tokyo); 1978 Feb; 26(2):429-34. PubMed ID: 639173
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased uptake and retention of rhodamine 123 by mitochondria of old human fibroblasts.
    Martinez AO; Vara C; Castro J
    Mech Ageing Dev; 1987 Jun; 39(1):1-9. PubMed ID: 3613685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC; Hutchinson DJ; Schmid FA; Philips FS
    Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
    Nakayama T; Sakamoto S; Sassa S; Suzuki S; Kudo H; Nagasawa H
    Anticancer Res; 2005; 25(1A):157-60. PubMed ID: 15816533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of thymidylate synthase in intact L1210 cells by ara-C, daunomycin, hydroxyurea and 3,4-dihydroxybenzylamine.
    FitzGerald GB; Ratliff J; Wick MM
    Anticancer Drug Des; 1987 Apr; 1(4):281-9. PubMed ID: 2967076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antitumor activity of 5-fluorouracil derivatives.
    Ozaki S
    Med Res Rev; 1996 Jan; 16(1):51-86. PubMed ID: 8788214
    [No Abstract]   [Full Text] [Related]  

  • 29. Methotrexate cytotoxicity as related to irreversible S phase arrest in mouse L1210 leukemia cells.
    Tsurusawa M; Niwa M; Katano N; Fujimoto T
    Jpn J Cancer Res; 1990 Jan; 81(1):85-90. PubMed ID: 2108951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
    Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
    Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial synchronization of L1210 cells by 5-fluorouracil and its use in drug combinations.
    Bhuyan BK; Blowers CL; Neil GL; Bono VH; Day KJ
    Cancer Res; 1977 Sep; 37(9):3204-8. PubMed ID: 560250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis.
    Bruckner HW; Schreiber C; Waxman S
    Cancer Res; 1975 Mar; 35(3):801-6. PubMed ID: 1116135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine.
    Neil GL; Berger AE; Bhuyan BK; DeSante DC
    Cancer Res; 1976 Mar; 36(3):1114-20. PubMed ID: 56229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.
    Takemura H; Urasaki Y; Yoshida A; Fukushima T; Ueda T
    Cancer Res; 2001 Jan; 61(1):172-7. PubMed ID: 11196156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electronic volume analysis of L1210 chemotherapy.
    Zucker RM; Helfman D
    Cancer Res; 1976 Dec; 36(12):4434-8. PubMed ID: 1000492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporation.
    Perez DJ; Tattersall MH
    Eur J Cancer Clin Oncol; 1983 Mar; 19(3):371-6. PubMed ID: 6683175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
    Schrecker AW; Goldin A
    Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
    [No Abstract]   [Full Text] [Related]  

  • 38. Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factor.
    Goldin A; Venditti JM; Kline I; Mantel N
    Nature; 1966 Dec; 212(5070):1548-50. PubMed ID: 21105503
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT; Craig RW; Agarwal RP
    Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymidylate synthase inhibition induces S-phase arrest, biphasic mitochondrial alterations and caspase-dependent apoptosis in leukaemia cells.
    Sakoff JA; Ackland SP
    Cancer Chemother Pharmacol; 2000; 46(6):477-87. PubMed ID: 11138461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.